- Joined
- Mar 18, 2016
- Messages
- 1
- Reaction score
- 0
TMS and tDCS are emerging therapies in a number of neurologic and psychiatric disease areas. Publications are building up in support of their use e.g. : http://stm.sciencemag.org/content/8/330/330re1
Until now, there hasn't been much clinical use. If research continues to be promising, I'm assuming this will change.
Who do you think will take responsibility for administering these therapies? Will it be subspecialist neurologists dealing with TMS and tDCS (perhaps alongside DBS, or alongside EMG/NCS)? Will it be neurologists focusing on each specific area administering their own protocols? Will it be neuroradiology, and if so, diagnostic or interventional?
Until now, there hasn't been much clinical use. If research continues to be promising, I'm assuming this will change.
Who do you think will take responsibility for administering these therapies? Will it be subspecialist neurologists dealing with TMS and tDCS (perhaps alongside DBS, or alongside EMG/NCS)? Will it be neurologists focusing on each specific area administering their own protocols? Will it be neuroradiology, and if so, diagnostic or interventional?